Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Learn what to look for in no fee cashback card comparisons. Make informed choices to maximize your financial benefits.
15,402 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Goldman Sachs trimmed its U.S. growth view as Iran-related tensions threaten more than higher oil prices. The shift s...
A new forecast warns that a 60-day Iran clash could push the federal deficit higher by about $65 billion, on top of t...
Investing in oil has a reputation for big moves and big headlines. This guide dives into vitesse energy stock your po...
A high-profile Arkansas event sparked financial ripples as sponsors and donors paused amid controversy. This article ...
Bitcoin surged to the $74,000 level, then reversed as selling pressure emerged near resistance. Traders are watching ...
AI-driven demand and easing supply bottlenecks push chipmakers into the spotlight. Here’s a timely look at the best s...
The battle between FedEx and UPS isn't just about packages—it's about dollars, margins, and future growth. This artic...
DC Blockchain Summit presses ahead in Washington as Dubai's Token2049 is delayed amid geopolitical risk, highlighting...
Conagra Brands is pouring $220 million into a key manufacturing upgrade, signaling confidence in demand. But does tha...
The past year reshaped The Trade Desk in ways that matter to investors. This article breaks down what changed, why it...
AI-powered venture activity in Q4 2025 shows a notable revival in healthtech, cybersecurity, biotech, and enterprise ...